Elliot Maltz

Chief Financial Officer, Gelesis.

Companies

Alimera SciencesChief financial officer Jan 4, 2024 to Sep 18, 2024¹
Orgenesis Inc.Chief financial officer Sep 5, 2023 to Sep 5, 2023²
GelesisChief financial officer Jan 24, 2022 to May 9, 2022³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Recent filings

May 6, 2022Granted 395,501 shares of CIK 1805087⁴
May 6, 2022Granted 31,392 shares of CIK 1805087⁴
May 6, 2022Granted 5,082 shares of CIK 1805087⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAlimera Sciences, Chief financial officer
2
SEC EDGAROrgenesis Inc., Chief financial officer
3
SEC EDGARGelesis, Chief financial officer
4
SEC EDGARForm 4 filed May 9, 2022